Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
CNS Pharmaceuticals, Inc. (CNSP) had Operating Cash Flow per Share of $-31.18 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.96M |
|
-- |
|
-- |
|
$5.99M |
|
$-5.99M |
|
$0.03M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.99M |
|
$-5.99M |
|
0.44M |
|
0.44M |
|
$-4.60 |
|
$-4.60 |
|
| Balance Sheet Financials | |
$8.10M |
|
$0.02M |
|
$0.52M |
|
$8.62M |
|
$4.10M |
|
-- |
|
-- |
|
$4.10M |
|
$4.52M |
|
$4.52M |
|
$4.52M |
|
0.63M |
|
| Cash Flow Statement Financials | |
$-13.81M |
|
$-0.02M |
|
$14.57M |
|
$6.46M |
|
$7.20M |
|
$0.74M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-131.69% |
|
-131.69% |
|
-69.07% |
|
-131.69% |
|
$7.14 |
|
$-31.22 |
|
|
Operating Cash Flow per Share |
$-31.18 |